0001874823-22-000002.txt : 20221004 0001874823-22-000002.hdr.sgml : 20221004 20221004121224 ACCESSION NUMBER: 0001874823-22-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221004 DATE AS OF CHANGE: 20221004 EFFECTIVENESS DATE: 20221004 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sensorium Therapeutics, Inc. CENTRAL INDEX KEY: 0001874823 IRS NUMBER: 863181021 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-460645 FILM NUMBER: 221290414 BUSINESS ADDRESS: STREET 1: 25 CRESCENT STREET STREET 2: UNIT 135 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 5626885433 MAIL ADDRESS: STREET 1: 25 CRESCENT STREET STREET 2: UNIT 135 CITY: WALTHAM STATE: MA ZIP: 02453 D 1 primary_doc.xml X0708 D LIVE 0001874823 Sensorium Therapeutics, Inc. 38 WAREHAM STREET FLOOR 2 BOSTON MA MASSACHUSETTS 02118 562-688-5433 DELAWARE None None Corporation true 2021 Richard Simon c/o Sensorium Therapeutics, Inc. 38 Wareham Street, Floor 2 Boston MA MASSACHUSETTS 02118 Executive Officer Director Jerrold Rosenbaum c/o Sensorium Therapeutics, Inc. 38 Wareham Street, Floor 2 Boston MA MASSACHUSETTS 02118 Director Pranav Tadi c/o Sensorium Therapeutics, Inc. 38 Wareham Street, Floor 2 Boston MA MASSACHUSETTS 02118 Executive Officer Kevin Lalande c/o Sensorium Therapeutics, Inc. 38 Wareham Street, Floor 2 Boston MA MASSACHUSETTS 02118 Director Ryan Katz c/o Sensorium Therapeutics, Inc. 38 Wareham Street, Floor 2 Boston MA MASSACHUSETTS 02118 Director Pharmaceuticals Decline to Disclose 06b false 2022-09-19 false true false 0 24789809 15512569 9277240 false 46 0 true 0 true The Company engaged Umergence LLC (CRD# 284368) to introduce investors to the Company in connection financing. 750000 true false Sensorium Therapeutics, Inc. /s/ Pranav Tadi Pranav Tadi VP, Head of Finance 2022-10-04